BR112012013719A2 - uso de transferrina no tratamento de ß-talassemias - Google Patents
uso de transferrina no tratamento de ß-talassemiasInfo
- Publication number
- BR112012013719A2 BR112012013719A2 BR112012013719A BR112012013719A BR112012013719A2 BR 112012013719 A2 BR112012013719 A2 BR 112012013719A2 BR 112012013719 A BR112012013719 A BR 112012013719A BR 112012013719 A BR112012013719 A BR 112012013719A BR 112012013719 A2 BR112012013719 A2 BR 112012013719A2
- Authority
- BR
- Brazil
- Prior art keywords
- thalassemia
- transferrin
- treatment
- reducing
- iron
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
uso de transferrina no tratamento de <225>-talassemias. são divulgados aqui os métodos para o tratamento de doença, tais como doenças de sobrecarga de ferro, incluindo <225>-talassemia, compreendendo a administração de pelo menos um curso da transferrina e assim reduzindo o tamanho do baço no referido paciente e reduzindo a concentração de ferro nos tecidos e no sangue.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26777209P | 2009-12-08 | 2009-12-08 | |
PCT/US2010/059543 WO2011072059A1 (en) | 2009-12-08 | 2010-12-08 | Use of transferrin in treatment of beta-thalassemias |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012013719A2 true BR112012013719A2 (pt) | 2016-03-15 |
Family
ID=43480422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012013719A BR112012013719A2 (pt) | 2009-12-08 | 2010-12-08 | uso de transferrina no tratamento de ß-talassemias |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130143817A1 (pt) |
EP (1) | EP2509621A1 (pt) |
AU (1) | AU2010328167B2 (pt) |
BR (1) | BR112012013719A2 (pt) |
CA (1) | CA2782397A1 (pt) |
IL (1) | IL220241A0 (pt) |
WO (1) | WO2011072059A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160243201A1 (en) * | 2013-11-05 | 2016-08-25 | New York Blood Center, Inc. | Methods and compositions for increasing hepcidin expession using modified iron binding/releasing transferrin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2395525A1 (en) * | 1999-12-23 | 2001-06-28 | Human Genome Sciences, Inc. | Transferrin polynucleotides, polypeptides, and antibodies |
US20050028229A1 (en) * | 2003-04-14 | 2005-02-03 | Mitchell Weiss | Alpha-hemoglobin stabilizing protein transgenic mouse and methods of use thereof |
WO2010147621A1 (en) * | 2009-06-16 | 2010-12-23 | The Trustees Of Columbia University In The City Of New York | Methods for ameliorating adverse effects associated with transfusion of aged red blood cells |
-
2010
- 2010-12-08 BR BR112012013719A patent/BR112012013719A2/pt not_active IP Right Cessation
- 2010-12-08 EP EP10788210A patent/EP2509621A1/en not_active Withdrawn
- 2010-12-08 AU AU2010328167A patent/AU2010328167B2/en not_active Withdrawn - After Issue
- 2010-12-08 WO PCT/US2010/059543 patent/WO2011072059A1/en active Application Filing
- 2010-12-08 US US13/809,848 patent/US20130143817A1/en not_active Abandoned
- 2010-12-08 CA CA2782397A patent/CA2782397A1/en not_active Abandoned
-
2012
- 2012-06-07 IL IL220241A patent/IL220241A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010328167A1 (en) | 2012-06-07 |
WO2011072059A1 (en) | 2011-06-16 |
CA2782397A1 (en) | 2011-06-16 |
IL220241A0 (en) | 2012-07-31 |
EP2509621A1 (en) | 2012-10-17 |
AU2010328167B2 (en) | 2014-05-08 |
US20130143817A1 (en) | 2013-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
PH12015500297A1 (en) | Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease | |
NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
BR112014016672A2 (pt) | compostos de carbamato e sua preparação e uso | |
NO20075136L (no) | Nye liposompreparater | |
SG158112A1 (en) | Hepatocyte growth factor (hgf) binding proteins | |
MX337575B (es) | Compuestos de sulfona y métodos para lafabricación y uso de éstos. | |
EA201791669A2 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
EP2381957A4 (en) | THERAPEUTIC MODULATION OF VAGINAL EPITHELIUM LIMITING LUBRICATION | |
MY155649A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
BRPI0906181A2 (pt) | "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer" | |
BR112013004917A2 (pt) | terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais. | |
UA108193C2 (uk) | Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
ES2356883A1 (es) | Composicion para el tratamiento del dolor y/o la inflamacion. | |
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
UY32882A (es) | (heteroarilmetil) tiohidantoínas sustituidas | |
BR112012006252A2 (pt) | "formas cristalinas de abt-263 e solvatos para o uso no tratamento de doenças relacionadas á proteína bcl-2". | |
IN2015DN02729A (pt) | ||
CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
EA200971107A1 (ru) | Катехоламиновые производные, полезные для лечения болезни паркинсона | |
EP4124346A3 (en) | Compositions and methods for treating diseases | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |